References
- Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary 2017;20:4-9 https://doi.org/10.1007/s11102-016-0754-x
- Lugo G, Pena L, Cordido F. Clinical manifestations and diagnosis of acromegaly. Int J Endocrinol 2012;2012:540398 https://doi.org/10.1155/2012/540398
- Bihan H, Espinosa C, Valdes-Socin H, et al. Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 2004;89:5308-5313 https://doi.org/10.1210/jc.2004-0821
- dos Santos Silva CM, Gottlieb I, Volschan I, et al. Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort. J Clin Endocrinol Metab 2015;100:4447-4455 https://doi.org/10.1210/jc.2015-2675
- Sharma AN, Tan M, Amsterdam EA, Singh GD. Acromegalic cardiomyopathy: epidemiology, diagnosis, and management. Clin Cardiol 2018;41:419-425 https://doi.org/10.1002/clc.22867
- Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16:69 https://doi.org/10.1186/s12968-014-0069-x
- Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 2016;18:89
- Dargad RR, Parekh JD, Dargad RR. Acromegaly with dilated cardiomyopathy. J Assoc Physicians India 2016;64:96-97
- Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD, Mergo PJ. Diffuse diseases of the myocardium: MRI-pathologic review of nondilated cardiomyopathies. AJR Am J Roentgenol 2013;200:W266-273 https://doi.org/10.2214/AJR.12.9633